The fish collagen peptides market is projected to grow at a notable pace by 2027 driven by the rising awareness about the benefits of the product, and escalating product demand in varied applications.

Fish collagen peptides are mainly found in the skin of fish and have several benefits. Since the COVID-19 outbreak, scientists have been seeking treatment solutions for the illness. Recent studies have found that certain peptides could be used a lead compounds to develop inhibitors potential inhibitors to defend against the COVID-19 infection, which is expected to positively influence industry outlook.

For extensive analysis, the fish collagen peptides market has been segmented on the basis of source, application, and region. Based on source, the market has been bifurcated into skin, scales, bones, and fins.

The fins sub-segment holds nearly 6.5% share in the fish collagen peptides market revenue and is estimated to see sizable growth over the assessment timeframe. Rising utilization of fish fins as potential raw material source is projected to drive segmental demand across the globe.

In terms of application, the market has been bifurcated into agriculture, cosmetics (haircare, skincare, and injectables), food & beverage, nutraceuticals (dietary supplements and functional food), pharmaceutical (musculoskeletal, cardiovascular diseases, endocrine supplements, and others), and animal nutrition (poultry, cattle, pork/swine, and pets).

Fish collagen peptides market from functional food segment is set to witness steady growth at over 4.0% CAGR through the assessment period. The skincare segment held a considerable share in the fish collagen peptides market revenue in 2020 and is expected to grow at over 5.4% CAGR over the study timeframe.

The injectables segment is projected to grow at a CAGR of more than 3.5% through the forecast timeline to amass a sizable revenue by the end of 2027. Fish collagen peptides market size from the musculoskeletal segment is anticipated to showcase considerable growth by 2027 at over 4.5% CAGR over the projected period.

The endocrine supplements segment is expected to see robust growth over 2021-2027, registering a CAGR of around 5.0% through the forecast time period. The others pharmaceutical application segment is expected to rise at a CAGR of above 1.5% over the assessment timeframe.

The poultry animal nutrition segment is anticipated to witness profitable growth at over 5.0% CAGR through the study timeline. The pork/swine segment accounts for a substantial share in the fish collagen peptides market in 2020 and is estimated to grow at a CAGR of above 4.5% through the assessment period.

The fish collagen peptides market from the cattle segment is expected to see lucrative growth at a CAGR of approximately 4.0% through the assessment time period. Escalating market demand across the animal nutrition industry is projected to drive segmental expansion over the following years.

The pets segment is speculated to grow at a CAGR of more than 4.5% through the forecast timeframe. Growing pet adoption across the globe and rising awareness regarding proper pet nutrition are likely to fuel industry gains through 2027.

The agriculture application segment holds over 2% share in the fish collagen peptides market and is speculated to rise substantially over 2021-2027. Surging product demand in the agricultural industry is anticipated to propel segmental adoption over the coming years.

In the regional landscape, Latin America contributes to over 4.5% share in the fish collagen peptides market revenue and is projected to expand at a considerable pace owing to rise in consumption of animal protein products across the globe. The Middle East & Africa fish collagen peptides market is calculated to rise at around 2.5% CAGR over the analysis period.